Join DARPA’s B-SAFE Industry Day for Groundbreaking Advances in Gene Editing Inhibitors - EverGlade Consulting

Join DARPA’s B-SAFE Industry Day for Groundbreaking Advances in Gene Editing Inhibitors

DARPA’s B-SAFE Industry Day

The Defense Advanced Research Projects Agency is hosting an Industry Day for the B-SAFE (Broad-Spectrum Antagonists for Editors) program on June 28, 2024, in Arlington, VA, with a webinar option available. This event is pivotal for those in the science and technology communities, including industry, academia, and government, who are interested in advancing gene editing technologies.

Event Details

  • Date: June 28, 2024
  • Location: Arlington, VA with Webinar Option
  • Time: 9:00 AM to 5:00 PM ET
  • Registration Deadlines:
    • In person: June 23, 2024, at 4:00 PM ET
    • Webinar: June 24, 2024, at 4:00 PM ET
  • Registration Website: Register Here

Program Objectives

The B-SAFE program aims to develop advanced inhibitors for gene editing tools like CRISPR-Cas systems. These inhibitors are crucial for ensuring precision, specificity, and control in genetic modifications. The program focuses on creating inhibitors for multiple classes of gene editors, enhancing the safety and efficacy of genome editing technologies.

Industry Day Goals

  1. Introduction to the B-SAFE Program: Attendees will learn about the vision and goals of the B-SAFE program, including its potential impacts on gene editing technology.
  2. DARPA Program Mechanics: Detailed explanations of how DARPA programs operate, including objectives and milestones specific to B-SAFE.
  3. Teaming Opportunities: Encouraging collaborations among organizations with the necessary expertise to drive forward research and development in line with B-SAFE goals.

Who Should Attend

  • Researchers and developers in biotechnology and genetic engineering.
  • Organizations with capabilities in bioinformatics, biochemical, and genetic methods for discovering and optimizing gene editing inhibitors.
  • Institutions interested in participating in DARPA’s innovative research programs.

Key Areas of Interest

  • Discovery and validation of new inhibitors using bioinformatic, biochemical, computational, or genetic methods.
  • High throughput screening to assess inhibitor efficacy and off-target effects.
  • Optimization of inhibitors to enhance performance and specificity.

Teaming and Networking

DARPA encourages attendees to form teams with complementary expertise. The registration website will allow participants to share their contact information and technical competencies, fostering potential collaborations.

How to Participate

Interested parties must register in advance to attend either in person or via webcast. Due to limited space, early registration is recommended. Non-U.S. citizens must submit additional documentation by June 19, 2024.

Contact Information

For more details, visit the DARPA Opportunities page or contact Dr. Shannon Greene at [email protected].

Don’t miss this opportunity to be at the forefront of groundbreaking advancements in gene editing technologies. Register now to secure your spot at DARPA’s B-SAFE Industry Day!

At EverGlade Consulting, we are committed to helping our clients navigate the complexities of grant applications and maximize their chances of securing funding. If you are interested in applying for this opportunity or need assistance with your application, please do not hesitate to contact us. Our team of experts is here to support you every step of the way. If your company has considered applying for NIH funding, your federal funding journey starts here.

Collaborate With Everglade Consulting

EverGlade Consulting is a national consulting firm connecting public sector needs with private sector solutions. We offer services ranging from Pursuit, Proposal, and Post-Award support to comply with federal regulations at agencies including BARDA, ASPR, NIH, DTRA, JPEO, DOD, DOE, and DARPA.

Contact Us

Recent Posts

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top